The first set of analyses have been published, showing that tau is predictor of a prolonged return to play. These samples were collected prior to the NCAA study being initiate. This resulted in a publication in Neurology. We also published finding related to gene-activity changes related to inflammation. We now have approval for samples from the NCAA to be delivered to NIH to initiate planned studies. In October we will begin proteomic studies to determine proteins that predicts return to play, we expect all samples to be analyzed by April, 2018. Publications will be submitted in the Spring of 2018.
|Osier, Nicole; Motamedi, Vida; Edwards, Katie et al. (2018) Exosomes in Acquired Neurological Disorders: New Insights into Pathophysiology and Treatment. Mol Neurobiol :|
|Gill, Jessica; Merchant-Borna, Kian; Jeromin, Andreas et al. (2017) Acute plasma tau relates to prolonged return to play after concussion. Neurology 88:595-602|
|Bogoslovsky, Tanya; Wilson, David; Chen, Yao et al. (2017) Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid ? up to 90 Days after Traumatic Brain Injury. J Neurotrauma 34:66-73|
|Bogoslovsky, Tanya; Gill, Jessica; Jeromin, Andreas et al. (2016) Fluid Biomarkers of Traumatic Brain Injury and Intended Context of Use. Diagnostics (Basel) 6:|
|Merchant-Borna, Kian; Lee, Hyunhwa; Wang, Dan et al. (2016) Genome-Wide Changes in Peripheral Gene Expression following Sports-Related Concussion. J Neurotrauma 33:1576-85|